COMPARISON OF OXIDATIVE STRESS MARKERS AND ANTI-OXIDANT DEFENSE SYSTEM IN ASTHAMATIC AND NON-ASTHAMATIC WOMEN DURING SECOND TRIMESTER OF PREGNANCY

Main Article Content

Faezah Siddiqui
Ali Awais Malik

Abstract

OBJECTIVE: To compare the levels of stress markers and anti-oxidants during the second trimester of pregnancy in healthy and asthmatic women.


METHODS:  This cross-sectional research, conducted at Institute of Molecular Biology and Biotechnology, University of Lahore and Pak Red Crescent Teaching Hospital, Dina Nath, from October 2016 to March 2017. One hundred females (50 healthy and 50 asthmatics) of same age group (20-35 years) and duration of pregnancy (second trimester) were included through purposive sampling technique. Oxidative stress markers [Melanodialdehyde (MDA) and Nitric Oxide (NO)], enzymatic [Superoxide Dismutase (SOD), Catalase (CAT), Glutathione Reductase (GSH) and Glutathione Peroxidase (GPx)] and non-enzymatic (Vitamin E, Vitamin C and Vitamin A) anti-oxidants were recorded.


RESULTS: Mean BMI was 21.55±0.35kg/m2 and 20.32±0.25kg/m2 (p-value=<0.001) in healthy and asthmatics respectively. Mean hemoglobin values were 12.21±0.21g/dl and 9.8±0.21g/dl (p-value=<0.001), in oxidative stress marker means, MDA had 1.52±0.75 and 2.86±1.18 (p-value=<0.001), while NO had 12.59±1.91 and 14.91±1.65 (p-value=<0.001) in healthy & asthmatics respectively. In Enzymatic anti-oxidant means, SOD had 0.50±0.19 and 0.15±0.21 (p-value=<0.001), CAT had 3.86±0.59 and 0.02±0.01 (p-value=<0.001), GSH had 9.36±1.01 and 4.27±1.91 (p-value=<0.001), while GPx had 9.48±1.01 and 0.36±0.13 (p-value=<0.001) in healthy & asthmatics respectively. In non- enzymatic anti-oxidant means, Vitamin C showed 0.58±0.18 and 0.38±0.09 (p-value=<0.001), Vitamin E had 0.71±0.13 and 0.34±0.11 (p-value=<0.001), while vitamin A depicted 0.45 ± 0.06 and 0.35 ± 0.11 (p-value=<0.001) in the healthy & asthmatics respectively.


CONCLUSION: Our study suggest that imbalance between reducing and oxidizing systems favors a more oxidative stress in asthmatic women than healthy controls during pregnancy.

Article Details

How to Cite
Siddiqui, F., and A. Malik. “COMPARISON OF OXIDATIVE STRESS MARKERS AND ANTI-OXIDANT DEFENSE SYSTEM IN ASTHAMATIC AND NON-ASTHAMATIC WOMEN DURING SECOND TRIMESTER OF PREGNANCY”. KHYBER MEDICAL UNIVERSITY JOURNAL, Vol. 12, no. 2, June 2020, pp. 81-5, doi:10.35845/kmuj.2020.19646.
Section
Original Articles

References

1. Aziz SS, Iqbal R. Asthma as a Respiratory Disorder: A Review. Sci Inquiry Rev 2018;2(2):42-59.
2. Kostakou E, Kaniaris E, Filiou E, et al. Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management. J Clin Med 2019;8(9):1283. DOI: 10.3390/jcm8091283.
3. Li Y, Zhang L, Wang X, Wu W, Qin R. Effect of Syringic acid on antioxidant biomarkers and associated inflammatory markers in mice model of asthma. Drug Dev Res 2019;80(2):253‐261. DOI: 10.1002/ddr.21487.
4. Dozor AJ. The role of oxidative stress in the pathogenesis and treatment of asthma. Ann N Y Acad Sci 2010;1203:133‐137. DOI: 10.1111/j.1749-6632.2010.05562.x.
5. Awofadeju SO. Enzymatic and Non-enzymatic Biomarkers Levels in Pregnancy Trimesters in Ilesa South Western Nigeria. Int Blood Res Rev 2016;6(4):1-11. DOI: 10.9734/ibrr/2016/29410.
6. Bahinipati J, Mohapatra PC. Ischemia Modified Albumin as a Marker of Oxidative Stress in Normal Pregnancy. J Clin Diagn Res 2016;10(9):BC15‐BC17. DOI: 10.7860/JCDR/2016/21609.8454.
7. Whelan GJ, Silkoff PE. Noninvasive Tests, Exhaled Nitric Oxide, and Exhaled Breath Condensate—Do They Help Diagnose Asthma? In: Castro M, Kraft M. Clinical Asthma. 1st ed. Elsevier Inc:2008. pp. 97-106. [Accessed on: July 27, 2019]. Available from URL: https://www.elsevier.com/books/clinical-asthma/9780323042895.
8. Riccioni G, Mancini B, Bucciarelli T, di Ilio C, D’Orazio N. Role of anti-oxidants in the treatment of bronchial asthma. Drug Discov Today Ther Strateg. 2006;3(3):293-8. DOI: 10.1016/j.ddstr.2006.09.010.
9. Samir D, Dalal D, Noura A. Study of Oxidative Stress during Pregnancy. Glob J Pharm Pharm Sci 2018;4(5):555646. DOI: 10.19080/gjpps.2018.04.555646.
10. Bishopp A, Sathyamurthy R, Manney S, Webbster C, Krishna MT, Mansur AH. Biomarkers of oxidative stress and antioxidants in severe asthma: A Prospective Case-Control Study. Ann Allergy Asthma Immunol. 2017;118(4):445‐51. DOI: 10.1016/j.anai.2017.02.004.
11. Parr CL, Magnus MC, Karlstad Ø, Holvik K, Lund-Blix NA, Haugen M, et al. Vitamin A and D intake in pregnancy, infant supplementation, and asthma development: the Norwegian Mother and Child Cohort. Am J Clin Nutr 2018;107(5):789-98. DOI: 10.1093/ajcn/nqy016.
12. McEvoy CT, Milner KF, Scherman AJ, Schilling DG, Tiller CJ, Vuylsteke B, et al. Vitamin C to Decrease the Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP): Rationale, design, and methods of a randomized, controlled trial of vitamin C supplementation in pregnancy for the primary prevention of effects of in utero tobacco smoke exposure on infant lung function and respiratory health. Contemp Clin Trials 2017;58:66-77. DOI: 10.1016/j.cct.2017.05.008.
13. Khan M, Ajmal MT. Prevalence of Asthma in Southern Punjab, Pakistan. Pak J Pharm Res 2016;2(1):33-6.
14. Horak F, Doberer D, Eber E, Horak E, Pohl W, Riedler J, et al. Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines. Wien Klin Wochenschr 2016;128(15-16):541-54. DOI: 10.1007/s00508-016-1019-4.
15. Kakkar P, Viswanathan PN. Superoxide Dismutase Isozymes and Toxicity of Environmental Xenobiotics. In: Biological Oxidation Systems. Elsevier Inc:1990. pp. 527-34. [Accessed on: July 27, 2019]. Available from URL: https://www.sciencedirect.com/book/9780125845519/biological-oxidation-systems.
16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351-8. DOI: 10.1016/0003-2697(79)90738-3.
17. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem. 1995 Jun;41(6 Pt 1):892-6.
18. Aebi H. Catalase. In: Methods of Enzymatic Analysis. New York;Verlag Chemie/Academic Press Inc:1974. p. 673-84. DOI: 10.1016/b978-0-12-091302-2.50032-3.
19. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979 Jan 4;582(1):67-78. DOI: 10.1016/0304-4165(79)90289-7.
20. Grieger JA, Wood LG, Clifton VL. Antioxidant-rich dietary intervention for improving asthma control in pregnancies complicated by asthma: study protocol for a randomized controlled trial. Trials 2014;15:108. DOI: 10.1186/1745-6215-15-108.
21. Reddy PH, Hemachandra Reddy P. Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics. Pharmaceuticals 2011;4(3):429-56. DOI: 10.3390/ph4030429.
22. Saleh JA, Suleiman SM, Zaidan ZJ. Determination of MDA as oxidative stress marker and most common type of blood group in asthmatic patients before and after treatment with montelukast drug. Tikrit J Pure Sci 2018;20(2):84-7.
23. El-Alameey IR, Fathy GA, Shady MMA, Ali A, Fathy HA, Youness ER, et al. Relationship of Oxidant and Antioxidant Markers to Asthma Severity in Egyptian Asthmatic Children. Open Access Maced J Med Sci 2017;5(5):645-50. DOI: 10.3889/oamjms.2017.149.
24. Ozaras R, Tahan V, Turkmen S, Talay F, Besirli K, Aydin S, et al. Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist. Respirology 2000;5(3):289-92. DOI: 10.1046/j.1440-1843.2000.00260.x.
25. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001;389(1):84‐93. DOI:10.1006/abbi.2001.2295.
26. Masri FA, Comhair SAA, Dostanic-Larson I, Kaneko FT, Dweik RA, Arroliga AC, et al. Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension. ClinTransl Sci 2008;1(2):99-106. DOI: 10.1111/j.1752-8062.2008.00035.x.
27. Gumral N, Caliskan S, Ozgüner F, Kaleli S, Akkaya A, Yilmaz H, et al. Melatonin levels and enzymatic antioxidant defense system decrease in blood of patients with bronchial asthma. Toxicol Ind Health. 2009 Jul;25(6):411-6. DOI: 10.1177/0748233709106625.
28. Al-Abdulla NO, Al Naama LM, Hassan MK. Antioxidant status in acute asthmatic attack in children. J Pak Med Assoc 2010;60(12):1023-7.
29. Sackesen C, Ercan H, Dizdar E, et al. A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. J Allergy Clin Immunol 2008;122(1):78‐85. DOI: 10.1016/j.jaci.2008.03.035.
30. Ali Z, Nilas L, Ulrik CS. Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: A case control study. Respir Med 2016;120:124-30. DOI: 10.1016/j.rmed.2016.10.004.